InfuSystems Holdings Inc Cash Flow Conversion Efficiency
InfuSystems Holdings Inc cash flow conversion efficiency. Based on the latest financial reports, InfuSystems Holdings Inc (INFU) has a cash flow conversion efficiency ratio of 0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($970.00K) by net assets ($58.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see INFU stock market capitalisation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of InfuSystems Holdings Inc (2005–2025)
Cash flow conversion efficiency of InfuSystems Holdings Inc from 2005 to 2025. This chart illustrates how InfuSystems Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View InfuSystems Holdings Inc share price for real-time trading data and today's change.
InfuSystems Holdings Inc Cash Flow Conversion Ratio Explained
InfuSystems Holdings Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
InfuSystems Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of InfuSystems Holdings Inc ranked by their cash flow conversion efficiency. Review how much free cash does InfuSystems Holdings Inc generate to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hup Seng Industries Bhd
KLSE:5024
|
0.093x |
|
Sabina Public Company Limited
BK:SABINA
|
0.101x |
|
Black Spade Acquisition II Co Unit
NASDAQ:BSIIU
|
-0.002x |
|
Southern Cross Media Group Ltd
AU:SXL
|
0.062x |
|
Associated British Foods PLC
LSE:ABF
|
0.067x |
|
Songwon Industrial
KO:004430
|
0.010x |
|
Compugen
TA:CGEN
|
0.049x |
|
Oriola-KD Oyj B
HE:OKDBV
|
0.229x |
Annual Cash Flow Conversion Efficiency for InfuSystems Holdings Inc (2005–2025)
The table below shows the annual cash flow conversion efficiency of InfuSystems Holdings Inc from 2005 to 2025. Also see InfuSystems Holdings Inc total assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $57.33 Million | $24.41 Million | 0.426x | +19.72% |
| 2024-12-31 | $57.53 Million | $20.46 Million | 0.356x | +65.73% |
| 2023-12-31 | $52.30 Million | $11.22 Million | 0.215x | -41.20% |
| 2022-12-31 | $48.00 Million | $17.52 Million | 0.365x | -3.83% |
| 2021-12-31 | $48.27 Million | $18.32 Million | 0.379x | -23.75% |
| 2020-12-31 | $40.75 Million | $20.28 Million | 0.498x | -19.90% |
| 2019-12-31 | $22.33 Million | $13.88 Million | 0.621x | +11.48% |
| 2018-12-31 | $20.44 Million | $11.39 Million | 0.557x | +127.47% |
| 2017-12-31 | $30.95 Million | $7.58 Million | 0.245x | +57.01% |
| 2016-12-31 | $50.69 Million | $7.91 Million | 0.156x | +13.42% |
| 2015-12-31 | $51.28 Million | $7.05 Million | 0.138x | -11.92% |
| 2014-12-31 | $46.45 Million | $7.25 Million | 0.156x | -10.59% |
| 2013-12-31 | $42.72 Million | $7.46 Million | 0.175x | +28.20% |
| 2012-12-31 | $40.01 Million | $5.45 Million | 0.136x | -23.69% |
| 2011-12-31 | $40.16 Million | $7.17 Million | 0.179x | +40.62% |
| 2010-12-31 | $85.14 Million | $10.81 Million | 0.127x | +6.56% |
| 2009-12-31 | $81.47 Million | $9.71 Million | 0.119x | -12.43% |
| 2008-12-31 | $80.07 Million | $10.90 Million | 0.136x | +113.78% |
| 2007-12-31 | $68.76 Million | $4.38 Million | 0.064x | +554.54% |
| 2006-12-31 | $65.15 Million | $-912.35K | -0.014x | -106.93% |
| 2005-12-31 | $-376.00 | $-76.00 | 0.202x | -- |
About InfuSystems Holdings Inc
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment … Read more